Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 120,000 | -72,000 | -611,000 | -212,000 | -937,000 |
| Depreciation Amortization | 1,302,000 | 1,322,000 | 1,352,000 | 1,493,000 | 1,607,000 |
| Income taxes - deferred | 80,000 | 66,000 | 51,000 | -176,000 | -225,000 |
| Accounts receivable | -134,000 | -216,000 | -195,000 | -57,000 | -229,000 |
| Accounts payable and accrued liabilities | -76,000 | 357,000 | 158,000 | -75,000 | 121,000 |
| Other Working Capital | -219,000 | 7,000 | -582,000 | -396,000 | -128,000 |
| Other Operating Activity | 327,000 | 133,000 | 859,000 | -1,305,000 | 1,217,000 |
| Operating Cash Flow | $1,400,000 | $1,597,000 | $1,032,000 | $-728,000 | $1,426,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -397,000 | -337,000 | -215,000 | -218,000 | 400,000 |
| Net Acquisitions | 7,000 | 7,000 | 5,000 | -40,000 | N/A |
| Purchase Of Investment | -215,000 | -148,000 | -1,917,000 | -17,000 | -19,000 |
| Sale Of Investment | 8,000 | 14,000 | 26,000 | 22,000 | 15,000 |
| Purchase Sale Intangibles | -10,000 | -3,000 | -57,000 | -50,000 | -14,000 |
| Other Investing Activity | 2,000 | 10,000 | -44,000 | -50,000 | 13,000 |
| Investing Cash Flow | $-595,000 | $-454,000 | $-2,145,000 | $-303,000 | $409,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,554,000 | 661,000 | 3,291,000 | 6,836,000 | 2,100,000 |
| Debt Repayment | -11,191,000 | -1,460,000 | -1,710,000 | -7,846,000 | -3,440,000 |
| Common Stock Issued | N/A | N/A | N/A | 675,000 | N/A |
| Other Financing Activity | -105,000 | -69,000 | -106,000 | -139,000 | -173,000 |
| Financing Cash Flow | $-742,000 | $-868,000 | $1,475,000 | $-474,000 | $-1,513,000 |
| Exchange Rate Effect | 61,000 | -36,000 | 9,000 | -23,000 | -19,000 |
| Beginning Cash Position | 1,201,000 | 962,000 | 591,000 | 2,119,000 | 1,816,000 |
| End Cash Position | 1,325,000 | 1,201,000 | 962,000 | 591,000 | 2,119,000 |
| Net Cash Flow | $124,000 | $239,000 | $371,000 | $-1,528,000 | $303,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,400,000 | 1,597,000 | 1,032,000 | -728,000 | 1,426,000 |
| Capital Expenditure | -397,000 | -337,000 | -215,000 | -218,000 | -269,000 |
| Free Cash Flow | 1,003,000 | 1,260,000 | 817,000 | -946,000 | 1,157,000 |